⌘K

Login Start Free

Home/Filings/4/0001968202-24-000113

4//SEC Filing

STAHL NEIL 4

Accession 0001968202-24-000113

CIK 0000872589other

View on SEC.gov Company Profile

Filed

Aug 5, 8:00 PM ET

Accepted

Aug 6, 4:03 PM ET

Size

9.5 KB

Accession

0001968202-24-000113

Insider Transaction Report

Form 4

Period: 2024-08-02

REGENERON PHARMACEUTICALS, INC.REGN

SVP Res and Dev Sciences

Transactions

Exercise/Conversion
Common Stock
2024-08-02$555.67/sh+23,638$13,134,927→ 74,637 total
Tax Payment
Common Stock
2024-08-02$1093.49/sh−18,441$20,165,049→ 56,196 total
Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2024-08-02−23,638→ 45,000 total
Exercise: $555.67Exp: 2025-12-16→ Common Stock (23,638 underlying)

Holdings

Common Stock
(indirect: By 401(k))
5,849
Common Stock
(indirect: By Trust)
4,605

Footnotes (1)

[F1]The stock option award vests in four equal annual installments, commencing one year after the date of grant.

Documents

1 file

4
edgardoc.xmlPrimary
PRIMARY DOCUMENT

Issuer

REGENERON PHARMACEUTICALS, INC.

CIK 0000872589

Entity typeother

Related Parties

1

filerCIK 0001226689

Filing Metadata

Form type: 4
Filed: Aug 5, 8:00 PM ET
Accepted: Aug 6, 4:03 PM ET
Size: 9.5 KB

View on SEC.gov